HF004
In those patients with a current diagnosis of heart failure due to left ventricular systolic dysfunction who are currently treated with an ACE-I or ARB, the percentage of patients who are additionally currently treated with a beta- blocker licensed for heart failure for heart failure
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF004 | 2019 | 84 | 95 | 88.4% | |
| HF004 | 2020 | 80 | 86 | 93.0% | |
| HF006 | 2021 | 81 | 94 | 86.2% | |
| HF006 | 2022 | 105 | 111 | 94.6% | |
| HF006 | 2023 | 190 | 208 | 91.3% |
